Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis

Breedveld FC(2006)The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26-37

Weisman MH(2006)TEMPO study investigators. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial Arthritis Rheum 54 1063-1074

Kavanaugh AF(2005)Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 3381-3390

Cohen SB(2007)The Utrecht rheumatoid arthritis cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) Ann Rheum Dis 66 1443-1449

Pavelka K(2010)Treating rheumatoid arthritis to target: recommendations of an international task force Ann Rheum Dis 69 631-637

Vollenhoven RV(1995)Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-48

Sharp J(2005)The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis Clin Exp Rheumatol 23 S100-1105

Perez JL(1995)Remission in a prospective study of patients with rheumatoid arthritis. American rheumatism association preliminary remission criteria in relation to the disease activity score Rheumatology. 35 1101-2415

Spencer-Green GT(2005)A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II) J Rheumatol 32 2410-92

van der Heijde D(2013)Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use Curr Med Res Opin 29 85-540

Breedveld FC(2006)The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26-37

Weisman MH(2006)TEMPO study investigators. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial Arthritis Rheum 54 1063-1074

Kavanaugh AF(2005)Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 3381-3390

Cohen SB(2007)The Utrecht rheumatoid arthritis cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) Ann Rheum Dis 66 1443-1449

Pavelka K(2010)Treating rheumatoid arthritis to target: recommendations of an international task force Ann Rheum Dis 69 631-637

Vollenhoven RV(1995)Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-48

Sharp J(2005)The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis Clin Exp Rheumatol 23 S100-1105

Perez JL(1995)Remission in a prospective study of patients with rheumatoid arthritis. American rheumatism association preliminary remission criteria in relation to the disease activity score Rheumatology. 35 1101-2415

Spencer-Green GT(2005)A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II) J Rheumatol 32 2410-92

van der Heijde D(2013)Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use Curr Med Res Opin 29 85-540